Association of E-cadherin, matrix metalloproteinases, and tissue inhibitors of metalloproteinases with the progression and metastasis of hepatocellular carcinoma

Parkin, 2005, Global cancer statistics, 2002, CA Cancer J Clin, 55, 74, 10.3322/canjclin.55.2.74 Niu, 2000, Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of Hepatocellular carcinoma, World J Gastroenterol, 6, 565 Akalin, 2001, Why hepatocellular carcinoma cells are unlikely to metastasize: is there a role for tissue inhibitor of Metalloproteinase-1?, Med Hypotheses, 57, 221, 10.1054/mehy.2001.1271 Olubuyide, 1992, The natural history of primary liver cell carcinoma: a study of 890 untreated adult Nigerians, Cent Afr J Med, 38, 25 Wijnhoven, 2000, E-cadherin–catenin cell–cell adhesion complex and human cancer, Br J Surg, 87, 992, 10.1046/j.1365-2168.2000.01513.x Kemler, 1993, From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion, Trends Genet, 9, 317, 10.1016/0168-9525(93)90250-L Berx, 1995, E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers, EMBO J, 14, 6107, 10.1002/j.1460-2075.1995.tb00301.x Berx, 1998, Mutations of human E-cadherin (CDH1) gene, Hum Mutat, 12, 226, 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D Inayoshi, 2003, Gross appearance of hepatocellular carcinoma reflects E-cadherin expression and risk of early recurrence after surgical treatment, J Gastroenterol Hepatol, 18, 673, 10.1046/j.1440-1746.2003.03021.x Saeki, 2000, Correlation between metastatic potency and the down-regulation of E-cadherin in the mouse hepatoma cell lines G-1 and G-5, Oncol Rep, 7, 731 Shinoyama, 1991, Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin in an indifferentiated carcinoma, Cancer Lett, 57, 131, 10.1016/0304-3835(91)90206-W Osada, 1996, E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma, Hepatology, 24, 1460, 10.1002/hep.510240627 Wei, 2002, Altered expression of E-cadherin in hepatocellular carcinoma: correlation with genetic alterations, β-catenin expression, and clinical features, Hepatology, 36, 692, 10.1053/jhep.2002.35342 Endo, 2000, Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and r-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters and patient survival, Hum Pathol, 31, 558, 10.1053/hp.2000.6683 Brikedal-hansen, 1993, Matrix metalloproteinases: a review, Crit Rev Oral Biol Med, 4, 197, 10.1177/10454411930040020401 Yoshimoto, 1993, Expression of MMP-7 (Pump-1) mRNA in human colorectal cancers, Int J Cancer, 54, 614, 10.1002/ijc.2910540415 Senota, 1998, Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer, Clin Exp Metastasis, 16, 313, 10.1023/A:1006509312674 Docherty, 1992, The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases, Trends Biotechnol, 10, 200, 10.1016/0167-7799(92)90214-G Matrisian, 1990, Metalloproteinases and their inhibitors in matrix remodeling, Trends Genet, 6, 121, 10.1016/0168-9525(90)90126-Q Lichtinghagen, 1995, Expression pattern of matrix metalloproteinases in human liver, Eur J Clin Chem Clin Biochem, 33, 65 Kossakowska, 1998, Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis, Am J Pathol, 153, 1895, 10.1016/S0002-9440(10)65703-3 Egeblad, 2002, New functions for the matrix metalloproteinases in cancer progression, Nat Rev Cancer, 2, 161, 10.1038/nrc745 Yang, 2001, Human macrophage metalloelastase gene expression in colorectal carcinoma and its clinicopathologic significance, Cancer, 91, 1277, 10.1002/1097-0142(20010401)91:7<1277::AID-CNCR1129>3.0.CO;2-H Takeha, 1997, Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: a novel approach from immune/inflammatory aspect, Jpn J Cancer Res, 88, 72, 10.1111/j.1349-7006.1997.tb00304.x Baker, 2002, Metalloproteinase inhibitors: biological actions and therapeutic opportunities, J Cell Sci, 115, 3719, 10.1242/jcs.00063 Curry, 2003, The matrix metalloproteinase system: changes, regulation, and impact through the ovarian and uterine reproductive cycle, Endocr Rev, 24, 428, 10.1210/er.2002-0005 Stratmann, 2001, MMP-TIMP interaction depends on residue 2 in TIMP4, FEBS Lett, 507, 285, 10.1016/S0014-5793(01)02987-8 Hirohashi, 2000, Hepatocellular carcinoma, 165 Wanless, 1995, Terminology of nodular hepatocellular lesions, Hepatology, 22, 983, 10.1002/hep.1840220341 Harris, 1990, Hepatocellular carcinogenesis: recent advances and speculations, Cancer Cells, 2, 146 Saito, 1990, Hepatitis C virus infection is associated with the development of hepatocellular carcinoma, Proc Natl Acad Sci USA, 87, 6547, 10.1073/pnas.87.17.6547 Chen, 1996, Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma, Hepatology, 24, 38, 10.1002/hep.510240108 Nazeako, 1996, Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinicohistopathologic study of 804 North American patients, Am J Clin Pathol, 105, 65, 10.1093/ajcp/105.1.65 Kew, 1989, Hepatocellular carcinoma with and without cirrhosis. A comparison in southern African blacks, Gastroenterology, 97, 136, 10.1016/0016-5085(89)91426-1 Okuda, 1989, Hepatocellular carcinoma without cirrhosis in Japanese patients, Gastroenterology, 97, 140, 10.1016/0016-5085(89)91427-3 Kakar, 2005, Clinicopathologic features and survival in Fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis, Mod Pathol, 18, 1417, 10.1038/modpathol.3800449 Gao, 2005, Predictive markers for the recurrence of hepatocellular carcinoma, J Surg Oncol, 92, 274, 10.1002/jso.20389 Takahara, 1995, Increased expression of matrix metalloproteinases-II in experimental liver fibrosis in rats, Hepatology, 21, 787, 10.1002/hep.1840210328 Nie, 2004, Expression of TIMP-1 and TIMP-2 in rats with hepatic fibrosis, World J Gastroenterol, 10, 86, 10.3748/wjg.v10.i1.86 Ihara, 1996, Expression of epithelial cadherin and α- and β-Catenins in nontumoral livers and hepatocellular carcinomas, Hepatology, 23, 1441 Matsumura, 2001, Frequent down-regulation of E-cadherin by genetic and epigenetic changes in malignant progression of hepatocellular carcinomas, Clin Cancer Res, 7, 594 Shimoyama, 1991, Caherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin in an undifferentiated carcinoma, Cancer Lett, 57, 131, 10.1016/0304-3835(91)90206-W Giannelli, 2002, Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma, Int J Cancer, 97, 425, 10.1002/ijc.1635 Sakamoto, 2000, Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma, Int J Oncol, 17, 237 Arri, 1996, Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential, Hepatology, 24, 316, 10.1002/hep.510240206 Grigioni, 1991, Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens, Am J Pathol, 138, 647 Yamamoto, 1997, Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma, Gastroenterology, 112, 1290, 10.1016/S0016-5085(97)70143-4 Ishikawa, 1996, Matrilysin is associated with progression of colorectal tumor, Cancer Lett, 107, 5, 10.1016/0304-3835(96)04336-4 Adachi, 1999, Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers, Gut, 45, 252, 10.1136/gut.45.2.252 Miwa, 2002, Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma, Cancer, 94, 428, 10.1002/cncr.10235 Ishii, 2003, A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma, J Exp Clin Cancer Res, 22, 461 Lichtinghagen, 2001, Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C, J Hepatol, 34, 239, 10.1016/S0168-8278(00)00037-4 Lu, 2003, Relationship between TIMP-3 expression and promoter methylation of TIMP-3 gene in hepatocellular carcinoma, Zhonghua Bing Li Xue Za Zhi, 32, 230 Nakatsukasa, 1996, Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas, Hepatology, 24, 82, 10.1002/hep.510240115 Coussens, 2002, Matrix metalloproteinase inhibitors and cancer: trials and tribulations, Science, 295, 2387, 10.1126/science.1067100